In Brief: Ethex' generic disopyramide
Executive Summary
Ethex' generic disopyramide: KV Pharmaceuticals subsidiary announces the availability of disopyramide phosphate 150 mg ER capsules Feb. 2. The extended-release anti-arrhythmia drug has been validated under terms of a June 1993 consent decree that followed a seizure action. FDA says most KV products seized have gone through the review process and expects more products to be made available. The Ethex drug is the only AB-rated generic alternative to Searle's Norpace...